e-learning
resources
Berlin 2008
Monday, 06.10.2008
Understanding allergic airway inflammation with the help of animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cholecystokinin octapeptide prevents experimental allergic lung injury and its mechnism
S. Ning, C. Bin, L. Shujin (Shijiazhuang, China)
Source:
Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Session:
Understanding allergic airway inflammation with the help of animal models
Session type:
Thematic Poster Session
Number:
2034
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ning, C. Bin, L. Shujin (Shijiazhuang, China). Cholecystokinin octapeptide prevents experimental allergic lung injury and its mechnism. Eur Respir J 2008; 32: Suppl. 52, 2034
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
The impact of anti-IgE treatment on the airway microbiome in asthma.
SCREENING FOR UNDERDIAGNOSED CHILDHOOD ASTHMA IN BATUMI (GEORGIA)
Related content which might interest you:
The effects of somatostatin analogue in lipopolysaccharide-induced acute lung injury
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Ghrelin attenuates lipopolysaccharide-induced acute lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 731s
Year: 2005
The sensory irritant receptor TRPA1 is essential for airway inflammation in the LPS mouse model of acute lung injury.
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
The PAR
2
-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004
Absence of proton-sensing TDAG8 protects against ovalbumin-induced allergic airway inflammation
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Anti-inflammatory activity of the bradykinin B1R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Modulatory effects of oral tolerance in lung tissue remodelling in a model of chronic allergic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 219s
Year: 2006
Local administration of nuclear factor-κB decoy oligodeoxinucleotides prevents allergic airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 170s
Year: 2002
Allergic lung inflammation induces pulmonary vascular hyperresponsiveness
Source: Eur Respir J 2006; 28: 370-377
Year: 2006
Attenuation of acethylcholine and antigen-induced lung parenchyma responsiveness by oral tolerance: a study in a model of chronic airway inflammation in guinea pigs
Source: Eur Respir J 2004; 24: Suppl. 48, 350s
Year: 2004
Oral tolerance attenuates airway remodelling in a model of chronic allergic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 591s
Year: 2006
Endotoxin potentiates allergic airway inflammation in ovalbumin sensitised and challenged mice
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Aerobic conditioning inhibits ovalbumin allergic sensitisation and airway inflammation in mice
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Narirutin inhibits airway inflammation in an allergic mouse model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
The pathology of the platelet‘s melatonin production in aspirin-induced asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007
Acute protective effect of estradiol on lung inflammation induced by an intestinal ischemic insult in male rats
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept